Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Interstitial Lung Disease in Primary Immunodeficiencies
  • Language: en
  • Pages: 132

Interstitial Lung Disease in Primary Immunodeficiencies

None

Immunoglobulin Therapy in the 21st Century: The Dark Side of the Moon
  • Language: en
  • Pages: 126

Immunoglobulin Therapy in the 21st Century: The Dark Side of the Moon

In the early decades since the introduction in the early '80s of immunoglobulin therapy many studies tried to identify which clinical indications might benefit from the therapy, which treatment’s schedules are effective and safe. It is universally accepted that immunoglobulin therapy is a life-saving treatment in patients with PID. The rise of new indications for further different clinical conditions resulted in a steady increase in demand for immunoglobulins. Currently the consumption of immunoglobulin for PID represents a small fraction of the market. In the recent past we have been observing: 1) An increase in the demand for plasma and in the consequent need to increase the number of do...

A Toolkit for Monitoring Immunoglobulin G Levels from Dried Blood Spots of Patients with Primary Immunodeficiencies
  • Language: en

A Toolkit for Monitoring Immunoglobulin G Levels from Dried Blood Spots of Patients with Primary Immunodeficiencies

  • Type: Book
  • -
  • Published: 2023
  • -
  • Publisher: Unknown

Abstract: Purpose This study assessed whether measuring immunoglobulin G (IgG) from dried blood spots (DBSs) using nephelometry is a suitable remote monitoring method for patients with primary immunodeficiencies (PID). Methods Patients receiving immunoglobulin replacement therapy for PID were included in this non-interventional single-arm study (DRKS-ID: DRKS00020522) conducted in Germany from December 4, 2019, to December 22, 2020. Three blood samples, two capillary DBSs (one mail-transferred and the other direct-transferred to the laboratory), and one intravenous were collected from each patient. IgG levels were determined using nephelometry. IgG levels were summarized descriptively, and s...

Interferon-driven Immune Dysregulation in Common Variable Immunodeficiency-associated Villous Atrophy and Norovirus Infection
  • Language: en

Interferon-driven Immune Dysregulation in Common Variable Immunodeficiency-associated Villous Atrophy and Norovirus Infection

  • Type: Book
  • -
  • Published: 2023
  • -
  • Publisher: Unknown

Abstract: Purpose About 15% of patients with common variable immunodeficiency (CVID) develop a small intestinal enteropathy, which resembles celiac disease with regard to histopathology but evolves from a distinct, poorly defined pathogenesis that has been linked in some cases to chronic norovirus (NV) infection. Interferon-driven inflammation is a prominent feature of CVID enteropathy, but it remains unknown how NV infection may contribute. Methods Duodenal biopsies of CVID patients, stratified according to the presence of villous atrophy (VA), IgA plasma cells (PCs), and chronic NV infection, were investigated by flow cytometry, multi-epitope-ligand cartography, bulk RNA-sequencing, and RT...

Bronchoalveolar Lavage Fluid Reflects a TH1-CD21low B-cell Interaction in CVID-related Interstitial Lung Disease
  • Language: en

Bronchoalveolar Lavage Fluid Reflects a TH1-CD21low B-cell Interaction in CVID-related Interstitial Lung Disease

  • Type: Book
  • -
  • Published: 2021
  • -
  • Publisher: Unknown

Abstract: Background: About 20% of patients with common variable immunodeficiency (CVID) suffer from interstitial lung disease (ILD) as part of a systemic immune dysregulation. Current understanding suggests a role of B cells in the pathogenesis based on histology and increased levels of BAFF and IgM associated with active disease corroborated by several reports which demonstrate the successful use of rituximab in CVID-ILD. It is debated whether histological confirmation by biopsy or even video-assisted thoracoscopy is required and currently not investigated whether less invasive methods like a bronchoalveolar lavage (BAL) might provide an informative diagnostic tool. Objective: To gain insi...

The ABACHAI Clinical Trial Protocol: Safety and Efficacy of Abatacept (s.c.) in Patients with CTLA-4 Insufficiency Or LRBA Deficiency: A Non Controlled Phase 2 Clinical Trial
  • Language: en

The ABACHAI Clinical Trial Protocol: Safety and Efficacy of Abatacept (s.c.) in Patients with CTLA-4 Insufficiency Or LRBA Deficiency: A Non Controlled Phase 2 Clinical Trial

  • Type: Book
  • -
  • Published: 2022
  • -
  • Publisher: Unknown

Abstract: Background Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) insufficiency and lipopolysaccharide-responsive and beige-like anchor protein (LRBA) deficiency are both complex immune dysregulation syndromes with an underlying regulatory T cell dysfunction due to the lack of CTLA-4 protein. As anticipated, the clinical phenotypes of CTLA-4 insufficiency and LRBA deficiency are similar. Main manifestations include hypogammaglobulinemia, lymphoproliferation, autoimmune cytopenia, immune-mediated respiratory, gastrointestinal, neurological, and skin involvement, which can be severe and disabling. The rationale of this clinical trial is to improve clinical outcomes of affected patients...

Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency
  • Language: en

Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency

  • Type: Book
  • -
  • Published: 2022
  • -
  • Publisher: Unknown

Abstract: Timely detection of portal hypertension as a manifestation in a subgroup of patients with common variable immunodeficiency (CVID) represents a challenge since it is usually not associated with liver cirrhosis. To identify relevant markers for portal hypertension, we evaluated clinical history, laboratory parameters, and abdominal ultrasound including liver elastography and biomarkers of extracellular matrix formation. Twenty seven (6%) of 479 CVID patients presented with clinically significant portal hypertension as defined by either the presence of esophageal varices or ascites. This manifestation occurred late during the course of the disease (11.8 years after first diagnosis of ...